Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In-depth profiling of the LiaR response of Bacillus subtilis.
Wolf D, Kalamorz F, Wecke T, Juszczak A, Mäder U, Homuth G, Jordan S, Kirstein J, Hoppert M, Voigt B, Hecker M, Mascher T. Wolf D, et al. Among authors: wecke t. J Bacteriol. 2010 Sep;192(18):4680-93. doi: 10.1128/JB.00543-10. Epub 2010 Jul 16. J Bacteriol. 2010. PMID: 20639339 Free PMC article.
The rhamnolipid stress response of Bacillus subtilis.
Wecke T, Bauer T, Harth H, Mäder U, Mascher T. Wecke T, et al. FEMS Microbiol Lett. 2011 Oct;323(2):113-23. doi: 10.1111/j.1574-6968.2011.02367.x. Epub 2011 Aug 24. FEMS Microbiol Lett. 2011. PMID: 22092710
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2023 Dec 28:S0161-6420(23)00933-8. doi: 10.1016/j.ophtha.2023.12.026. Online ahead of print. Ophthalmology. 2023. PMID: 38158159 Free article.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
[Central venous occlusion in Wyburn-Mason syndrome].
Toepffer AM, Wecke T, Hoffmann MB, Thieme H. Toepffer AM, et al. Among authors: wecke t. Ophthalmologe. 2020 Apr;117(4):376-378. doi: 10.1007/s00347-019-0927-x. Ophthalmologe. 2020. PMID: 31209569 German.
18 results